Fig. 1From: Hypoxia-cleavable and specific targeted nanomedicine delivers epigenetic drugs for enhanced treatment of breast cancer and bone metastasisThe combined effect of JQ1 and icaritin in inhibiting breast cancer cells. (A) MTT assay of 4T1 cells treated with JQ1 and icaritin (n = 6). (B) The combination index of JQ1 and icaritin at different concentration ratios (n = 6). (C) Apoptosis analysis of 4T1 cells treated with JQ1 and icaritin (n = 3). (D) Quantitative analysis of the apoptosis of 4T1 cells treated with different drugs (n = 3). (E) Colony formation assay of 4T1 cells treated with JQ1 and icaritin (n = 3). F and G) Protein expression of c-myc was determined by western blotting analysis (n = 3). All data are presented as the mean ± SD. *p < 0.05, **p < 0.01Back to article page